
|Articles|October 1, 2017
- Pharmaceutical Executive-10-01-2017
- Volume 37
- Issue 10
Pharmaceutical Executive, October 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive October 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 8 years ago
Pharm Exec's Emerging Pharma Leaders 2017almost 9 years ago
How Pharmas, Payers, and Providers Can Meet the ‘Triple Aim’almost 9 years ago
Glimmers of Hope for Innovation Support in Europealmost 9 years ago
The Future of Real-World Studiesalmost 9 years ago
Inspiring People, Inspiring Teamsalmost 9 years ago
Country Report: ColombiaAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Pannel Votes to Loosen Restrictions for Four Peptides
2
Where the True Bottlenecks Exist at FDA for Clinical Trials
3
argenx Acquires Forte Biosciences for $2.2 Billion
4
Moving From Symptom Management to Disease Modification in Parkinson’s Research: Q&A with Dr. Jan Stoehr
5




